RenovoRx, Inc.
RNXT
$0.85
-$0.02-2.77%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.12M | 928.00K | 662.00K | 240.00K | 43.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.12M | 928.00K | 662.00K | 240.00K | 43.00K |
| Cost of Revenue | 327.00K | 299.00K | 246.00K | 94.00K | -- |
| Gross Profit | 796.00K | 629.00K | 416.00K | 146.00K | 43.00K |
| SG&A Expenses | 7.05M | 5.92M | 5.37M | 5.34M | 4.99M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.13M | 12.55M | 11.91M | 11.84M | 11.01M |
| Operating Income | -12.01M | -11.62M | -11.25M | -11.60M | -10.97M |
| Income Before Tax | -11.17M | -11.11M | -10.66M | -10.16M | -8.81M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.17 | -11.11 | -10.66 | -10.16 | -8.81 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.17M | -11.11M | -10.66M | -10.16M | -8.81M |
| EBIT | -12.01M | -11.62M | -11.25M | -11.60M | -10.97M |
| EBITDA | -12.01M | -8.99M | -5.79M | -3.11M | -- |
| EPS Basic | -0.32 | -0.35 | -0.37 | -0.39 | -0.39 |
| Normalized Basic EPS | -0.19 | -0.22 | -0.23 | -0.24 | -0.24 |
| EPS Diluted | -0.32 | -0.35 | -0.37 | -0.39 | -0.39 |
| Normalized Diluted EPS | -0.19 | -0.22 | -0.23 | -0.24 | -0.24 |
| Average Basic Shares Outstanding | 141.27M | 129.73M | 118.02M | 105.49M | 89.04M |
| Average Diluted Shares Outstanding | 141.27M | 129.73M | 118.02M | 105.49M | 89.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |